Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 12 results.
User Information
Export Records
  1. 1.   Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12
  2. Amlin-Van Schaick, J. C.; Kim, S.; DiFabio, C.; Lee, M. H.; Broman, K. W.; Reilly, K. M.
  3. Neuro-Oncology. 2012, Feb; 14(2): 160-174.
  1. 2.   Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapies
  2. Gursel, D. B.; Connell-Albert, Y. S.; Tuskan, R. G.; Anastassiadis, T.; Walrath, J. C.; Hawes, J. J.; Amlin-Van Schaick, J. C.; Reilly, K. M.
  3. Neuro-Oncology. 2011, Jun; 13(6): 610-621.
  1. 3.   Schweinfurthin A Selectively Inhibits Proliferation and Rho Signaling in Glioma and Neurofibromatosis Type 1 Tumor Cells in a NF1-GRD-Dependent Manner
  2. Turbyville, T. J.; Gursel, D. B.; Tuskan, R. G.; Walrath, J. C.; Lipschultz, C. A.; Lockett, S. J.; Wiemer, D. F.; Beutler, J. A.; Reilly, K. M.
  3. Molecular Cancer Therapeutics. 2010, May; 9(5): 1234-1243.
  1. 4.   Bioluminescent Approaches for Measuring Tumor Growth in a Mouse Model of Neurofibromatosis
  2. Hawes, J. J.; Reilly, K. M.
  3. Toxicologic Pathology. 2010, Jan; 38(1): 123-130.
  1. 5.   Proteomic analysis of protein expression changes in a model of gliomagenesis
  2. McBee, J. K.; Yu, L. R.; Kinoshita, Y.; Uo, T.; Beyer, R. P.; Veenstra, T. D.; Morrison, R. S.
  3. Proteomics Clinical Applications. 2007, Nov; 1(11): 1485-1498.
  1. 6.   Isolation and characterization of stem cell-like precursor cells from primary human anaplastic oligoastrocytoma
  2. Yi, L.; Zhou, Z. H.; Ping, Y. F.; Chen, J. H.; Yao, X. H.; Feng, H.; Lu, J. Y.; Wang, J. M.; Bian, X. W.
  3. Modern Pathology. 2007, Oct; 20(10): 1061-1068.
  1. 7.   Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies
  2. Hawes, J. J.; Tuskan, R. G.; Reilly, K. M.
  3. Neurogenetics. 2007, Apr; 8(2): 121-130.
  1. 8.   The importance of genome architecture in cancer susceptibility - Location, location, location
  2. Reilly, K. M.
  3. Cell Cycle. 2004, NOV; 3(11): 1378-1382.
  1. 9.   Synergistic effect of dexamethasone and beta-adrenergic receptor agonists on the nerve growth factor gene transcription
  2. Colangelo, A. M.; Mallei, A.; Johnson, P. F.; Mocchetti, I.
  3. Molecular Brain Research. 2004 124(2): 97-104.
  1. 10.   Expression of functional formyl peptide receptors by human astrocytoma cell lines
  2. Le, Y. Y.; Hu, J. Y.; Gong, W. H.; Shen, W. P.; Li, B. Q.; Dunlop, N. M.; Halverson, D. O.; Blair, D. G.; Wang, J. M.
  3. Journal of Neuroimmunology. 2000 111(1-2): 102-108.
  1. 11.   Beta-Adrenergic Receptor-Induced Activation of Nerve Growth Factor Gene Transcription in Rat Cerebral Cortex Involves Ccaat/Enhancer-Binding Protein Delta
  2. Colangelo, A. M.; Johnson, P. F.; Mocchetti, I.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1998 95(18): 10920-10925.
  1. 12.   Abrogation of Rb Tumor Suppression Initiates GBM in Differentiated Astrocytes by Driving a Progenitor Cell Program
  2. Adhikari, Amit S; Sullivan,Teresa; Bargaje, Rhishikesh; Lu, Lucy; O'Sullivan,Theresa; Song,Yurong; Van Dyke, Terry
  3. Frontiers in Oncology. 2022 12: 904479.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel